Patents-Review.com
ClassID:

96531 ⎘

C07J21/008 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton; Ketals at position 17

Recent Application in this class:
#1
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #2
20240287125
2024-08-29

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #3
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #4
20230279044
2023-09-07

Neuroactive steroids, compositions, and uses thereof

 #5
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #6
20230096870
2023-03-30

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #7
20220402965
2022-12-22

STEROL ANALOGS AND USES THEREOF

 #8
20220112203
2022-04-14

Small molecules active against gram-negative bacteria

 #9
20220064207
2022-03-03

Neuroactive steroids and methods of use thereof

 #10
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #11
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #12
20210269474
2021-09-02

Intermediates for the preparation of 11-methylene steroids

 #13
20210179661
2021-06-17

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #14
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #15
20210061848
2021-03-04

Neuroactive steroids, compositions, and uses thereof

 #16
20210017219
2021-01-21

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #17
20200407292
2020-12-31

Method for aromatic fluorination

 #18
20200291058
2020-09-17

Inhibitors of glucocorticoid receptor

 #19
20200239390
2020-07-30

Method for aromatic fluorination

 #20
20200055892
2020-02-20

Inhibitors of glucocorticoid receptor

 #21
20200024302
2020-01-23

Neuroactive steroids, compositions, and uses thereof

 #22
20200017542
2020-01-16

Neuroactive steroids, compositions, and uses thereof

 #23
20190284227
2019-09-19

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #24
20190202758
2019-07-04

Method for aromatic fluorination

 #25
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #26
20190152891
2019-05-23

Complex and structurally diverse compounds

 #27
20190135821
2019-05-09

Small molecules active against gram-negative bacteria

 #28
20190127414
2019-05-02

Neuroactive steroids and methods of use thereof

 #29
20190092807
2019-03-28

Process and new intermediates for the preparation of 11-methylene steroids

 #30
20190077826
2019-03-14

METHODS FOR PREPARING DEOXYCHOLIC ACID

 #31
20190047939
2019-02-14

PROCESS AND INTERMEDIATES FOR THE PRODUCTION OF 17(20)-ENE B-SECO STEROIDS

 #32
20180237470
2018-08-23

Neuroactive steroids and methods of use thereof

 #33
20180215779
2018-08-02

Neuroactive steroids, compositions, and uses thereof

 #34
20180111960
2018-04-26

Methods for preparing deoxycholic acid

 #35
20180037602
2018-02-08

Neuroactive steroids, compositions, and uses thereof

 #36
20170355728
2017-12-14

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #37
20170334944
2017-11-23

Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #38
20170305960
2017-10-26

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #39
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #40
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #41
20170152282
2017-06-01

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #42
20160251391
2016-09-01

Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors

 #43
20160244478
2016-08-25

Method for preparing 6-alkylated steroidal derivatives and corresponding alkylated 5,6,7,8-tetrahydronaphthalene-2(4 alpha.H)-ones

 #44
20160031929
2016-02-04

Inhibitors of CYP17A1

 #45
20160009751
2016-01-14

C-19 HYDROXY PREGNENES

 #46
20150274638
2015-10-01

Complex and structurally diverse compounds

 #47
20150259376
2015-09-17

Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #48
20150031875
2015-01-29

Combined synthesis route for desogestrel and etonogestrel

 #49
20140309443
2014-10-16

Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #50
20140249120
2014-09-04

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #51
20140235600
2014-08-21

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #52
20140088053
2014-03-27

Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10

 #53
20130123523
2013-05-16

METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL

 #54
20110028711
2011-02-03

Unsaturated Steroid Compounds

 #55
20090181936
2009-07-16

Diene and triene compounds and formulations

 #56
20090176752
2009-07-09

Diene compounds and formulations

 #57
20080070881
2008-03-20

Prostate cancer treatment

 #58
20080009472
2008-01-10

Prostate cancer treatment

 #59
20080004250
2008-01-03

Steroids having 1,8-unsaturation and formulations comprising same

 #60
20060211857
2006-09-21

6,7-Oxygenated steroids and uses related thereto

 #61
20050234251
2005-10-20

Process and new intermediates for the preparation of steroids with a progestogen activity

 #62
20050192263
2005-09-01

17β-hydroxysteroid dehydrogenase type I inhibitors